0001178913-12-003049.txt : 20121106
0001178913-12-003049.hdr.sgml : 20121106
20121106172300
ACCESSION NUMBER: 0001178913-12-003049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120822
FILED AS OF DATE: 20121106
DATE AS OF CHANGE: 20121106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sank Leonard
CENTRAL INDEX KEY: 0001416089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50298
FILM NUMBER: 121184142
MAIL ADDRESS:
STREET 1: 3 BLAIR ROAD
CITY: CAPE TOWN
STATE: T3
ZIP: 8005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0831
BUSINESS ADDRESS:
STREET 1: 2 ELZA STREET
CITY: JERUSALEM
STATE: L3
ZIP: 93706
BUSINESS PHONE: 011 972-54-7909058
MAIL ADDRESS:
STREET 1: 2 ELZA STREET
CITY: JERUSALEM
STATE: L3
ZIP: 93706
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4
1
zk1212211.xml
OWNERSHIP DOCUMENT
X0306
4
2012-08-22
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP.OB
0001416089
Sank Leonard
3 BLAIR ROAD
CAPE TOWN
T3
8005
SOUTH AFRICA
1
0
0
0
Common Stock
2012-08-22
4
A
0
270270
0.2717
A
2627920
D
Common Stock
2012-11-02
4
A
0
135135
0.2717
A
2763055
D
Common Stock
937500
I
See Footnote
Common Stock
1666667
I
See Footnote
Warrant (right to buy)
0.50
2012-08-22
4
A
0
135135
0.0983
A
2017-08-22
Common Stock
135135
135135
D
Warrant (right to buy)
0.50
2012-11-02
4
A
0
67568
0.0983
A
2017-11-02
Common Stock
67568
67568
D
Includes 937,500 shares of common stock held by Mr. Sank's wife. Mr. Sank disclaims beneficial ownership of such securities.
Includes 1,666,667 shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of such securities.
The warrant was fully vested on the date of issuance.
The shares and warrants were purchased as "units" at a price per unit of $0.37 in connection with the Issuer's 2012 private placement. The consideration was allocated to the shares and warrants based on relative fair value. The value allocated to the warrants was estimated by using the Black Scholes option-pricing model.
/s/ Leonard Sank
2012-11-06